Elicio Therapeutics, Inc. (ELTX) Operating cash flow 2020–2025
Elicio Therapeutics, Inc. (ELTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$37.0MFY2025 · since FY2020: -$22.9M → -$37.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.0M | +0.3% |
| FY2024 | -$37.1M | -13.4% |
| FY2023 | -$32.7M | -47.4% |
| FY2022 | -$22.2M | +57.9% |
| FY2021 | -$52.6M | -130.0% |
| FY2020 | -$22.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice